Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML |
Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD |
Reach Grants |
2017 |
Wisconsin |
Development of MicroRNA-Nanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements |
University of Cincinnati College of Medicine / Jianjun Chen, PhD |
Innovation Grants |
2013 |
Ohio |
Is SIRT5 a Therapy Target in Acute Lymphoblastic Leukemia? |
University of Utah / Michael Deininger, MD/PhD |
Innovation Grants |
2018 |
Utah |
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |
Nuclear Receptor Tyrosine Kinases Mediating Chromatin Remodeling & Checkpoint Adaption |
Children's Cancer Therapy Development Institute / Charles Keller, MD |
Innovation Grants |
2018 |
Oregon |
A Nurse-Led Structured Discharge Teaching Intervention for Parents of Newly Diagnosed Pediatric Oncology Patients |
University of Alabama at Birmingham / Wendy Landier, RN/PhD |
Nurse Researcher Grants |
2016 |
Alabama |
End-of-Life Care of Children with Cancer: Variation and Stakeholder Priorities |
University of Alabama at Birmingham / Emily Johnston, MD |
Young Investigator Grants |
2017 |
Alabama |
Investigating the role of BAI1 in the Metastasis of Medulloblastoma |
University of Alabama at Birmingham / Satoru Osuka, MD/PhD |
Young Investigator Grants |
2018 |
Alabama |
DNA Methylation Inhibitor Therapy for Testicular Germ Cell Tumors |
University of Illinois, Urbana-Champaign / Michael Spinella, Ph.D. |
Reach Grants |
2014 |
Illinois |
Identifying Therapeutic Targets to Prevent Progression of Familial RUNX1 Disorder to AML Using Novel iPSC Models |
Icahn School of Medicine at Mount Sinai / Eirini Papapetrou, MD/PhD |
Familial RUNX1 Research Grants |
2016 |
New York |